Differences in Treatment Characteristics and Patient and Therapist Satisfaction Between Robot Assisted Therapy and Conventional Occupational Therapy Among Individuals Post Stroke

The purpose of this study is to compare the differences in treatment characteristics and patient and therapist satisfaction, between Robot Assisted Therapy (RAT) and Conventional Occupational Therapy (COT) single session in individuals post stroke.

Study Overview

• Status: Completed
• Conditions: Stroke; CVA (Cerebrovascular Accident)
• Intervention / Treatment: Other: Robot Assisted Therapy (RAT)

Detailed Description

Method and research procedure: The study will include 30 sub-acute post stroke patients, aged 18-85, with severe motor impairment in the upper limb and with normal-mild cognitive ability, hospitalized at the Loewenstein Rehabilitation Hospital. Each subject will receive two 30-min treatment sessions, one Conventional Occupational Therapy (COT) and one Robot Assisted Therapy (RAT). Before and during each session, the Visual Analogue Scale (VAS) for reporting the level of pain will be administered. The number of repetitions and compensations will be counted by observation. After each session, a subjective satisfaction questionnaire regarding the treatment will be administered.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Israel
  • Raanana, Israel
    • Loewenstein

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. 18 to 85 year old following stroke (first-ever stroke).
2. Individuals in the sub-acute phase (up to three months)
3. Intact cognitive function (score > 21 points on the Mini Mental State Examination)
4. Sever weakness of the affected upper limb (score 5-20 points on the FMA)
5. Understanding and reading Hebrew
6. Normal or corrected eyesight.
7. Subjects were at least in one session of RAT and one session of COT

Exclusion Criteria:

1. Neurological, cardio-vascular or orthopedic impairment, unrelated to the stroke, which restrict upper limb function.
2. High muscle tone (score > 4 in Modified Ashworth Scale)
3. Apraxia (score <68 in De Renzi Apraxia Test)
4. Severe Sensory impairment.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Other: Therapy; Each subject will receive two 30-min treatment sessions, one Robot Assisted Therapy and one Conventional Occupational Therapy.

Other: Robot Assisted Therapy (RAT); Robot Assisted Therapy (RAT): 30-min treatment session of active- assisted movements of shoulder and elbow, using a robotic arm and a computer screen, provides different exercises according to the motor ability of the patient. The robot provides proximal upper limb training in a three-dimensional (3D) environment. The occupational therapist will be planning the treatment by determining the range of motion, the amount of help and support and the level of difficulty of the game. Conventional occupational therapy (COT): 30-min treatment session of active- assisted movements of the shoulder and elbow, using conventional facilities and devices. Treatment includes passive range of motion exercises and active- assistive exercises. The level of support and help will be determined by the occupational therapist.; Other Names: Conventional occupational therapy (COT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Observation	The number of repetitions and compensations will be counted by observation	30 min

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
VAS	The Visual Analogue Scale (VAS) is a common scale for estimating pain level from one to ten.	1min
Questionnaire	A subjective satisfaction questionnaire regarding the treatment will be administered.	5 min

Collaborators and Investigators

• Sponsor: linor kennet
• Collaborators: Tel Aviv University

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2020
• Primary Completion (Actual): August 1, 2022
• Study Completion (Actual): August 1, 2022

Study Registration Dates

• First Submitted: February 16, 2026
• First Submitted That Met QC Criteria: February 16, 2026
• First Posted (Actual): February 20, 2026

Study Record Updates

• Last Update Posted (Actual): February 20, 2026
• Last Update Submitted That Met QC Criteria: February 16, 2026
• Last Verified: February 1, 2026

More Information

Terms related to this study

• Keywords: Upper Extremity Paresis; Robot Assisted Therapy
• Additional Relevant MeSH Terms: Neurologic Manifestations; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Pathological Conditions, Signs and Symptoms; Signs and Symptoms; Stroke; Paresis
• Other Study ID Numbers: 0020-20-LOE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No